Tumor vaccination using messenger RNA: prospects of a future therapy
- 30 June 2011
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 23 (3) , 399-406
- https://doi.org/10.1016/j.coi.2011.03.007
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Bildung und Forschung
This publication has 50 references indexed in Scilit:
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor ActivityJournal of Immunotherapy, 2011
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccinationProceedings of the National Academy of Sciences, 2010
- Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivoGene Therapy, 2010
- 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-IProceedings of the National Academy of Sciences, 2009
- Recognition of 5′ Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand VirusImmunity, 2009
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma PatientsJournal of Immunotherapy, 2009
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNAJournal of Immunotherapy, 2008
- Toward the harmonization of immune monitoring in clinical trials: Quo vadis?Cancer Immunology, Immunotherapy, 2007
- mRNA transfection of dendritic cells: Synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression levelBiochemical and Biophysical Research Communications, 2005
- Induction of Anti-Tumor Immunity with Epidermal Cells Pulsed with Tumor-Derived RNA or Intradermal Administration of RNAJournal of Investigative Dermatology, 2000